Fda clears reader for abbott's freestyle libre® 3 system

Abbott park, ill., april 14, 2023 /prnewswire/ -- abbott (nyse: abt) today announced that the u.s. food and drug administration (fda) has cleared a reader for its freestyle libre® 3 integrated continuous glucose monitoring (icgm) system, which features the world's smallest, thinnest and most discreet5 glucose sensor.

ABT Ratings Summary

ABT Quant Ranking